RE:RE:Can someone explain why ? :(They are not done there final validation ? Refer to June 22, 2016, press release validation phase step # 3.
Press release from Sep 13/16 " We now look forward to the final stage of functional validation to select for drug development the mab products that block the neurotoxicity and propagation of the prion-like forms of AB"
They might have some of this last step completed, but have not reported. Maybe they are letting Pharma companies do this last piece, this would provide product proof ?